ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Clinical trial NCT00101920 · COMPLETED

Trial details

NCT number: NCT00101920
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Neoplasm Metastasis Lung Cancer

Start date: 2003-06-01
Primary completion: 2004-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.